Prevalence of Osteoporosis Among Patients with Rheumatoid Arthritis

Mahran Othman  Rasool; Dashty Abbas  Al-Bustany

doi:10.56056/

Authors

Mahran Othman Rasool MBChB, Department of Rheumatology, Rizgary Teaching Hospital, Erbil -Iraq.
Dashty Abbas Al-Bustany MBCHB, DIM, FICMS (Medicine), FRCP (UK-London)., Consultant Rheumatologist & Internist, Prof. in Medicine, Department of medicine, College of medicine, Hawler Medical University

DOI:

https://doi.org/10.56056/

Keywords:

Body mass index, Osteoporosis, Rheumatoid arthritis, risk factors

Abstract

Background and objectives: Rheumatoid arthritis is an autoimmune disease characterized by inflammation of the joints. The aim of this study was to investigate the prevalence of osteoporosis among patients with rheumatoid arthritis in Erbil city.

Methods: A cross-sectional study was conducted in Rizgary and Hawler Teaching Hospital that started from September 2022 to September 2023. A convenient sample of hundred patients was included in the study. Rheumatoid arthritis patients were assessed in a cross-sectional design by Dual Energy X-ray Absorptiometry Scan T-score. All participants registered an initial two paged questionnaire form; a verbal consent was achieved from all patients. Bone densitometry solution was used in Hawler Teaching Hospital and to be calibrated to their standards.

Results: Patients with rheumatoid arthritis in whom bone mineral density was measured, 31 patients (31 %) had osteoporosis, 33 patients (33%) had osteopenia, 36 patients (36%) had normal result. Odd ratio (OR), its 95% confidence interval was calculated for results with positive finding from baseline characteristics. For example, Patients with osteoporosis had longer disease duration (≥7 years; OR= 2.84, 95 % CI: 1.03 to 7.83, P= 0.042).

Conclusion: Osteoporosis is prevalent among rheumatoid arthritis patients in Erbil city. The prevalence was significant among lower body mass index, steroid users and old age post menopause patients.

Downloads

Download data is not yet available.

References

1. Porter JL, Varacallo M, Castano M. Osteoporosis (Nursing) In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK568781/

2. Hu Z, Zhang L, Lin Z, Zhao C, Xu S, Lin H, et al. Prevalence and risk factors for bone loss in rheumatoid arthritis patients from South China: modeled by three methods. BMC Musculoskelet Disord. 2021 Jun 12;22(1):534. doi: 10.1186/s12891-021-04403-5/

3. Fardellone P, Salawati E, Le Monnier L, Goëb V. Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review. J Clin Med. 2020 Oct 20;9(10):3361. doi: 10.3390/jcm9103361/

4. Phuan-Udom R, Lektrakul N, Katchamart W. The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis. Clin Rheumatol. 2018 Oct;37(10):2603-2610. doi: 10.1007/s10067-018-4218-8. Epub 2018 Jul 23.

5. Lin YC, Li YH, Chang CH, Hu CC, Chen DW, Hsieh PH, et al. Rheumatoid arthritis patients with hip fracture: a nationwide study. Osteoporos Int. 2015 Feb;26(2):811-7. doi: 10.1007/s00198-014-2968-y. Epub 2014 Nov 20.

6. ‏ Mazzucchelli R, Pérez Fernandez E, Crespí-Villarías N, Quirós-Donate J, García Vadillo A, Espinosa M, et al. Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study. RMD Open. 2018 Jun 4;4(1): e000671. doi: 10.1136/rmdopen-2018-000671/

7. ‏ Nyhäll-Wåhlin BM, Ajeganova S, Petersson IF, Andersson M. Increased risk of osteoporotic fractures in Swedish patients with rheumatoid arthritis despite early treatment with potent disease-modifying anti-rheumatic drugs: a prospective general population-matched cohort study. Scand J Rheumatol. 2019 Nov;48(6):431-438. doi: 10.1080/03009742.2019.1611918. Epub 2019 Jul 19.

8. Meng J, Li Y, Yuan X, Lu Y. Evaluating osteoporotic fracture risk with the Fracture Risk Assessment Tool in Chinese patients with rheumatoid arthritis. Medicine (Baltimore). 2017 May;96(18): e6677. doi: 10.1097/MD.0000000000006677/

9. Sun T, Wang J, Zhang R, Li Y. A systematic review and meta-analysis: effects of glucocorticoids on rheumatoid arthritis and systemic lupus erythematosus. Ann Palliat Med. 2021 Jul;10(7):7977-7991. doi: 10.21037/apm-21-1485. Epub 2021 Jul 8.

10. Jin S, Hsieh E, Peng L, Yu C, Wang Y, Wu C, et al. Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int. 2018 Jun;29(6):1263-1275. doi: 10.1007/s00198-018-4473-1. Epub 2018 Mar 15.

11. Llorente I, García-Castañeda N, Valero C, González-Álvaro I, Castañeda S. Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons. Front Med (Lausanne). 2020 Nov 23; 7:601618. doi: 10.3389/fmed.2020.601618/

12. Salari N, Ghasemi H, Mohammadi L, Behzadi MH, Rabieenia E, Shohaimi S, et al. The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021 Oct 17;16(1):609. doi: 10.1186/s13018-021-02772-0/

13. Kim D, Cho SK, Park B, Jang EJ, Bae SC, Sung YK. Glucocorticoids Are Associated with an Increased Risk for Vertebral Fracture in Patients with Rheumatoid Arthritis. J Rheumatol. 2018 May;45(5):612-620. doi: 10.3899/jrheum.170054. Epub 2018 Mar 15.

14. Corrado A, Rotondo C, Mele A, Cici D, Maruotti N, Sanpaolo E, et al. Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis. Arthritis Res Ther. 2021 Jul 6;23(1):180. doi: 10.1186/s13075-021-02562-3/

15. Rotta D, Fassio A, Rossini M, Giollo A, Viapiana O, Orsolini G, et al. Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment. Front Med (Lausanne). 2020 Dec 1; 7:613720. doi: 10.3389/fmed.2020.613720/

16. Innala L, Sjöberg C, Möller B, Ljung L, Smedby T, Södergren A, et al. Co-morbidity in patients with early rheumatoid arthritis - inflammation matters. Arthritis Res Ther. 2016 Jan 28; 18:33. doi: 10.1186/s13075-016-0928-y/

17. Hu Z, Xu S, Lin H, Ni W, Yang Q, Qi J, et al. Prevalence and risk factors for bone loss in Southern Chinese with rheumatic diseases. BMC Musculoskelet Disord. 2020 Jun 30;21(1):416. doi: 10.1186/s12891-020-03403-1/

18. Ramírez J, Nieto-González JC, Curbelo Rodríguez R, Castañeda S, Carmona L. Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018 Aug;48(1):44-52. doi: 10.1016/j.semarthrit.2017.12.001/

19. Chen P, Li Z, Hu Y. Prevalence of osteoporosis in China: a meta-analysis and systematic review. BMC Public Health. 2016 Oct 3;16(1):1039. doi: 10.1186/s12889-016-3712-7/

20. Kostoglou-Athanassiou I, Athanassiou P, Lyraki A, Raftakis I, Antoniadis C. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab. 2012 Dec;3(6):181-7. doi: 10.1177/2042018812471070/

21. Lee YH, Bae SC. Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis. Clin Exp Rheumatol. 2016 Sep-Oct;34(5):827-833.